Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning--is there still an upper age limit? A focus on myeloid neoplasia
- PMID: 17508002
- DOI: 10.1038/sj.leu.2404741
Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning--is there still an upper age limit? A focus on myeloid neoplasia
Abstract
Allogeneic haematopoietic cell transplantation (HCT) is the most effective curative therapy in acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). Incidence of AML and MDS increases with age, peaking in the seventh decade. Despite improved Ara-C and anthracyclin-based chemotherapy regimens, the prognosis of AML in patients beyond 60 years of age is dismal. The introduction of peripheral blood-derived stem cell grafts into allogeneic HCT and the known anti-leukaemic effect of donor lymphocyte infusions paved the way for reduced-intensity conditioning (RIC) allogeneic stem-cell transplantation, which makes transplant in advanced age possible and significantly reduces transplant-related organ toxicity and mortality. The success of RIC HCT relies on the alloreactivity of the donor immune system and the graft-versus-leukaemia effect. We try to answer the following questions in this paper: who should receive RIC HCT? when and how should the transplant be performed? is there an upper age limit and what is the future of RIC HCT?
Similar articles
-
[Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):969-74. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718102 Review. Chinese.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012. Biol Blood Marrow Transplant. 2009. PMID: 19135940
-
Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.Best Pract Res Clin Haematol. 2006;19(4):825-38. doi: 10.1016/j.beha.2006.06.007. Best Pract Res Clin Haematol. 2006. PMID: 16997186 Review.
-
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.Bone Marrow Transplant. 2007 Nov;40(9):843-50. doi: 10.1038/sj.bmt.1705801. Epub 2007 Aug 27. Bone Marrow Transplant. 2007. PMID: 17724447
Cited by
-
Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.Expert Rev Hematol. 2010 Feb 1;3(1):23-33. doi: 10.1586/ehm.09.73. Expert Rev Hematol. 2010. PMID: 20383269 Free PMC article. Review.
-
Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group.Int J Hematol. 2010 Jan;91(1):97-103. doi: 10.1007/s12185-009-0473-4. Epub 2010 Jan 5. Int J Hematol. 2010. PMID: 20047095 Clinical Trial.
-
How old is too old for a transplant?Best Pract Res Clin Haematol. 2021 Mar;34(1):101243. doi: 10.1016/j.beha.2021.101243. Epub 2021 Jan 12. Best Pract Res Clin Haematol. 2021. PMID: 33762098 Free PMC article. Review.
-
Challenges in treating older patients with acute myeloid leukemia.J Oncol. 2010;2010:943823. doi: 10.1155/2010/943823. Epub 2010 Jun 10. J Oncol. 2010. PMID: 20628485 Free PMC article.
-
Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.Biol Blood Marrow Transplant. 2014 Jun;20(6):816-22. doi: 10.1016/j.bbmt.2014.02.020. Epub 2014 Feb 26. Biol Blood Marrow Transplant. 2014. PMID: 24582782 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous